Patents by Inventor Angelika Banzhoff

Angelika Banzhoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140363468
    Abstract: Current approaches to influenza vaccination focus either on seasonal strains or pandemic strains. Current seasonal vaccines typically include antigens from two influenza A strains (H1N1 and H3N2) and one influenza B strain. Current pandemic vaccines focus on H5N1 influenza A virus strains. It is an object of the invention to provide further and improved ways of preparing vaccines that can raise immunity against both seasonal and pandemic strains.
    Type: Application
    Filed: August 18, 2014
    Publication date: December 11, 2014
    Inventors: Angelika BANZHOFF, Ralf Leo CLEMENS
  • Publication number: 20110200635
    Abstract: Current approaches to influenza vaccination focus either on seasonal strains or pandemic strains. Current seasonal vaccines typically include antigens from two influenza A strains (H1N1 and H3N2) and one influenza B strain. Current pandemic vaccines focus on H5N1 influenza A virus strains. It is an object of the invention to provide further and improved ways of preparing vaccines that can raise immunity against both seasonal and pandemic strains.
    Type: Application
    Filed: June 12, 2009
    Publication date: August 18, 2011
    Inventors: Angelika Banzhoff, Ralf Leo Clemens
  • Publication number: 20100034830
    Abstract: The invention provides for an immunogenic rabies vaccine comprising a reduced vaccine dose and methods of pre- and post-exposure immunization with a reduced dose. The concentration of rabies vaccine antigen per dose is preferably less than 2.5 IU/mL.
    Type: Application
    Filed: July 9, 2009
    Publication date: February 11, 2010
    Inventors: Angelika Banzhoff, Claudius Malerczyk
  • Publication number: 20060275776
    Abstract: The invention provides for an immunogenic rabies vaccine comprising a reduced vaccine dose and methods of pre- and post-exposure immunization with a reduced dose. The concentration of rabies vaccine antigen per dose is preferably less than 2.5 IU/mL.
    Type: Application
    Filed: June 1, 2005
    Publication date: December 7, 2006
    Inventors: Angelika Banzhoff, Claudius Malerczyk